Literature DB >> 24243240

Using phage as a platform to select cancer cell-targeting peptides.

Xin Li1, Chuanbin Mao.   

Abstract

One challenge in the development of cancer therapies is the availability of cancer-specific ligands. Recently, phage-displayed peptide libraries have been used for the selection of peptide-based cell-targeting ligands, especially cancer cell ligands. Here we describe the methods to identify SKBR-3 breast cancer cell-specific peptides from a phage-displayed random peptide library. It is possible to select both cell-surface-binding and cell-internalizing peptides using this method. This method can also be applied to the selection of targeting peptides for other adherent cancer cells. The identified short peptides can be potentially incorporated into a variety of early diagnostic and targeted therapeutic systems against breast cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24243240      PMCID: PMC4288844          DOI: 10.1007/978-1-62703-751-8_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

1.  Selection of peptides with semiconductor binding specificity for directed nanocrystal assembly.

Authors:  S R Whaley; D S English; E L Hu; P F Barbara; A M Belcher
Journal:  Nature       Date:  2000-06-08       Impact factor: 49.962

Review 2.  New approaches for cell-specific targeting: identification of cell-selective peptides from combinatorial libraries.

Authors:  K C Brown
Journal:  Curr Opin Chem Biol       Date:  2000-02       Impact factor: 8.822

3.  A DNA-binding peptide from a phage display library.

Authors:  J Wölcke; E Weinhold
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2001 Apr-Jul       Impact factor: 1.381

4.  Evolutionary selection of new breast cancer cell-targeting peptides and phages with the cell-targeting peptides fully displayed on the major coat and their effects on actin dynamics during cell internalization.

Authors:  Gopal Abbineni; Sita Modali; Barbara Safiejko-Mroczka; Valery A Petrenko; Chuanbin Mao
Journal:  Mol Pharm       Date:  2010-08-25       Impact factor: 4.939

5.  Organ targeting in vivo using phage display peptide libraries.

Authors:  R Pasqualini; E Ruoslahti
Journal:  Nature       Date:  1996-03-28       Impact factor: 49.962

Review 6.  Therapeutic cancer targeting peptides.

Authors:  Olulanu H Aina; Thomas C Sroka; Man-Ling Chen; Kit S Lam
Journal:  Biopolymers       Date:  2002       Impact factor: 2.505

7.  Neuroblastoma tumor cell-binding peptides identified through random peptide phage display.

Authors:  J Zhang; H Spring; M Schwab
Journal:  Cancer Lett       Date:  2001-10-10       Impact factor: 8.679

8.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.

Authors:  G P Smith
Journal:  Science       Date:  1985-06-14       Impact factor: 47.728

9.  Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells.

Authors:  Mohsen Shadidi; Mouldy Sioud
Journal:  FASEB J       Date:  2002-12-18       Impact factor: 5.191

Review 10.  Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions.

Authors:  R M Reilly; J Sandhu; T M Alvarez-Diez; S Gallinger; J Kirsh; H Stern
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

View more
  2 in total

1.  Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies.

Authors:  Franklin L Nobrega; Débora Ferreira; Ivone M Martins; Maria Suarez-Diez; Joana Azeredo; Leon D Kluskens; Lígia R Rodrigues
Journal:  BMC Cancer       Date:  2016-11-14       Impact factor: 4.430

2.  Selection of Novel Peptides Homing the 4T1 CELL Line: Exploring Alternative Targets for Triple Negative Breast Cancer.

Authors:  Vera L Silva; Debora Ferreira; Franklin L Nobrega; Ivone M Martins; Leon D Kluskens; Ligia R Rodrigues
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.